Quantra QPlus System
Coagulation System For The Measurement Of Whole Blood Viscoelastic Properties. 510(k) K223433, from Hemosonics, LLC (Durham, NC). Product code QFR, class 2.
As of Nov 18, 2026, K223433 is an FDA 510(k) held by Hemosonics, LLC, substantially equivalent on Dec 13, 2022 after 29 days, with no recalls tied to it in FDA's recall database.
- Review time: 29 days
- Recalls: 0
- Cited as a predicate by: 1 device
Indications for use
As the 510(k) summary states them, read from FDA's summary PDFThe Quantra® QPlus® System is composed of the Quantra Hemostasis Analyzer, QPlus Cartridge, and Quantra Quality Controls Level 1 and 2. The Quantra QPlus System is intended for in vitro diagnostic use.
Predicate devices
The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF- Quantra Hemostasis Analyzer, QPlus CartridgeDEN180017 · Hemosonics, LLC · Mar 12, 2019
Cited as a predicate
1 later 510(k) summary names this device as a predicate- Quantra Hemostasis AnalyzerK230461 · Hemosonics, LLC · Mar 24, 2023
Other QFR clearances
The newest 510(k)s for the same product code; their median review was 82 days; see every QFR device- Quantra QStat CartridgeK251404 · Hemosonics, LLC · Aug 25, 2025
- QStat CartridgeK240045 · Hemosonics, LLC · Mar 27, 2024
- Quantra Hemostasis AnalyzerK232215 · Hemosonics, LLC · Aug 24, 2023
- Quantra Hemostasis AnalyzerK230461 · Hemosonics, LLC · Mar 24, 2023
- QStat CartridgeK213917 · Hemosonics, LLC · Nov 29, 2022
Record
- Document
- 510(k) summary (PDF) ↗
- Type
- Special
- Received
- Nov 14, 2022
- Review panel
- Hematology
- Regulation
- 21 CFR 864.5430
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files